{
    "2018-11-30": [
        [
            {
                "time": "2018-12-28",
                "original_text": "U.S. Stocks Sprint Ahead to End a Blockbuster Week",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Stocks",
                        "Sprint",
                        "Blockbuster"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-28",
                "original_text": "Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock",
                        "Buy Zone",
                        "AbbVie",
                        "Humira",
                        "Biosimilar"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-28",
                "original_text": "3 Beaten-Down Biotech Stocks to Buy Before the End of 2018",
                "features": {
                    "keywords": [
                        "Beaten-Down",
                        "Biotech",
                        "Stocks",
                        "Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-28",
                "original_text": "AbbVie Rises 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rises"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-28",
                "original_text": "The New Amazon Blockchain Products Could Be Huge for AMZN",
                "features": {
                    "keywords": [
                        "Amazon",
                        "Blockchain",
                        "Products",
                        "AMZN"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-28",
                "original_text": "U.S.-China Trade Talks In Focus, While Just One Stock Sector Stands Out",
                "features": {
                    "keywords": [
                        "U.S.-China",
                        "Trade",
                        "Talks",
                        "Sector"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-01",
                "original_text": "Key Pharma Players With HIV Focus Ahead of World Aids Day",
                "features": {
                    "keywords": [
                        "Pharma",
                        "HIV",
                        "World Aids Day"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-28",
                "original_text": "AbbVie Announces HUMIRAÂ® (adalimumab) Global Patent License with Pfizer",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "HUMIRA",
                        "Patent",
                        "License",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-28",
                "original_text": "Pfizer Reaches Global Agreement With AbbVie; To Withdraw Pending Litigation",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Global",
                        "Agreement",
                        "AbbVie",
                        "Litigation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}